[Federal Register Volume 69, Number 107 (Thursday, June 3, 2004)]
[Notices]
[Page 31414]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-12466]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 21, 2004, Research 
Triangle Institute, Kenneth H. Davis Jr., Hermann Building East 
Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 
27709, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------

    The Institute will manufacture small quantities of cocaine 
derivatives and marihuana derivatives for use by their customers 
primarily in analytical kits, reagents and standards.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: Federal Register Representative, 
Office of Chief Counsel (CCD) and must be filed no later than August 2, 
2004.

    Dated: May 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-12466 Filed 6-2-05; 8:45 am]
BILLING CODE 4410-09-M